Rosanna Lagos

Summary

Affiliation: Universidad de Chile
Country: Chile

Publications

  1. doi request reprint Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007
    Rosanna Lagos
    Centro para Vacunas en Desarrollo, Chile, Hospital de Niños Roberto del Rio, Santiago, Chile
    J Infect Dis 198:1809-17. 2008
  2. ncbi request reprint Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age
    Rosanna Lagos
    Centro para Vacunas en Desarollo, Santiago, Chile
    Hum Vaccin 1:112-7. 2005
  3. pmc Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised)
    Wendy A Keitel
    Department of Molecular Virology and Microbiology, Houston, TX, USA
    BMC Res Notes 6:177. 2013
  4. ncbi request reprint [Direct medical costs of invasive pneumococcal disease and radiologically-diagnosed pneumonia among Chilean children]
    Rosanna Lagos
    Centro para Vacunas en Desarrollo Chile, Santiago, Chile
    Rev Panam Salud Publica 26:101-11. 2009
  5. doi request reprint Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants
    Rosanna Lagos
    Hospital de Niños Roberto del Rio, Servicio de Salud Metropolitano Norte, Santiago, Chile
    Vaccine 27:2299-305. 2009
  6. ncbi request reprint [Retrospective assessment of laboratory surveillance for invasive Streptococcus pneumoniae isolates from adults of the Metropolitan Region (Chile): 2000-2006]
    Aurora Maldonado
    Hospital de Niños Roberto del Rio, Centro para Vacunas en Desarrollo, Santiago, Chile
    Rev Chilena Infectol 24:446-52. 2007
  7. ncbi request reprint Characterization of the most prevalent colonization factor antigens present in Chilean clinical enterotoxigenic Escherichia coli strains using a new multiplex polymerase chain reaction
    Roberto M Vidal
    Faculty of Medicine, University of Chile, Santiago, 8389100, Chile
    Diagn Microbiol Infect Dis 65:217-23. 2009
  8. ncbi request reprint Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile
    Rosanna Lagos
    Centro para Vacunas en Desarrollo, Santiago, Chile
    Pediatr Infect Dis J 21:1115-23. 2002
  9. ncbi request reprint Safety and immunogenicity of a meningococcal (Groups A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine in healthy children aged 2 to 10 years in Chile
    Rosanna Lagos
    Centro para Vacunas en Desarrollo, Santiago, Chile
    Hum Vaccin 1:228-31. 2005
  10. ncbi request reprint Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of santiago, chile
    Noelia Fullá
    Programa de Microbiologia, Instituto de Ciencias Biomedicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
    Am J Trop Med Hyg 72:851-4. 2005

Collaborators

Detail Information

Publications14

  1. doi request reprint Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007
    Rosanna Lagos
    Centro para Vacunas en Desarrollo, Chile, Hospital de Niños Roberto del Rio, Santiago, Chile
    J Infect Dis 198:1809-17. 2008
    ..We monitored pediatric invasive pneumococcal disease (IPD) in Santiago, Chile, from 1994 to 2007...
  2. ncbi request reprint Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age
    Rosanna Lagos
    Centro para Vacunas en Desarollo, Santiago, Chile
    Hum Vaccin 1:112-7. 2005
    ..To assess the safety, immunogenicity and lot consistency of a liquid hexavalent combined vaccine (DTaP-IPV-PRP approximately T-HBs, HEXAVAC) (Sanofi-Pasteur MSD, France) administered to infants at two, four and six months of age...
  3. pmc Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised)
    Wendy A Keitel
    Department of Molecular Virology and Microbiology, Houston, TX, USA
    BMC Res Notes 6:177. 2013
    ..Sera were tested for the presence and level of HAI and neutralizing antibodies against the A(H1N1)pdm09 virus...
  4. ncbi request reprint [Direct medical costs of invasive pneumococcal disease and radiologically-diagnosed pneumonia among Chilean children]
    Rosanna Lagos
    Centro para Vacunas en Desarrollo Chile, Santiago, Chile
    Rev Panam Salud Publica 26:101-11. 2009
    ..To determine the direct medical costs of health care services for cases of invasive pneumococcal disease (IPD) and pneumonia acquired in the community and confirmed by radiology (NAC-Rx) among Chilean children...
  5. doi request reprint Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants
    Rosanna Lagos
    Hospital de Niños Roberto del Rio, Servicio de Salud Metropolitano Norte, Santiago, Chile
    Vaccine 27:2299-305. 2009
    ..Overall, interactions of PCV9, MnCC and Hib affected the magnitude (GMC) of the primary antibody responses to some of the antigens, but not the percentage of subjects who achieved protective antibody thresholds...
  6. ncbi request reprint [Retrospective assessment of laboratory surveillance for invasive Streptococcus pneumoniae isolates from adults of the Metropolitan Region (Chile): 2000-2006]
    Aurora Maldonado
    Hospital de Niños Roberto del Rio, Centro para Vacunas en Desarrollo, Santiago, Chile
    Rev Chilena Infectol 24:446-52. 2007
    ..In the perspective of future evaluations of the impact of this intervention, the results of this study indicate the need of reinforcing adherence and improving the quality of notifications of invasive S. pneumoniae...
  7. ncbi request reprint Characterization of the most prevalent colonization factor antigens present in Chilean clinical enterotoxigenic Escherichia coli strains using a new multiplex polymerase chain reaction
    Roberto M Vidal
    Faculty of Medicine, University of Chile, Santiago, 8389100, Chile
    Diagn Microbiol Infect Dis 65:217-23. 2009
    ..The method described here proved to be rapid and robust and correlates well with phenotypic expression of the CFAs, becoming a novel molecular diagnostic and research tool for future epidemiologic studies...
  8. ncbi request reprint Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile
    Rosanna Lagos
    Centro para Vacunas en Desarrollo, Santiago, Chile
    Pediatr Infect Dis J 21:1115-23. 2002
    ....
  9. ncbi request reprint Safety and immunogenicity of a meningococcal (Groups A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine in healthy children aged 2 to 10 years in Chile
    Rosanna Lagos
    Centro para Vacunas en Desarrollo, Santiago, Chile
    Hum Vaccin 1:228-31. 2005
    ..Seroconversion was evident in > 97% of MCV-4 and > 90% of PSV-4 vaccinees who tested seronegative at baseline. Menactra safely induced broad and robust immune responses against serogroups A, C, Y and W-135 in this population...
  10. ncbi request reprint Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of santiago, chile
    Noelia Fullá
    Programa de Microbiologia, Instituto de Ciencias Biomedicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
    Am J Trop Med Hyg 72:851-4. 2005
    ..Continuous monitoring of resistance patterns in Shigella is essential for establishing and updating guidelines for antibiotic treatment in shigellosis...
  11. pmc Single multiplex PCR assay to identify simultaneously the six categories of diarrheagenic Escherichia coli associated with enteric infections
    Maricel Vidal
    Programa de Microbiologia, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile
    J Clin Microbiol 43:5362-5. 2005
    ....
  12. ncbi request reprint [The use of chest X-rays for surveillance of bacterial pneumonias in children in Latin America]
    Rosanna Lagos
    Centro para Vacunas en Desarrollo Chile, Hospital de Niños Roberto del Rio, Santiago, Chile
    Rev Panam Salud Publica 13:294-302. 2003
    ..The activities carried out so far show both the need for and the feasibility of standardizing the interpretation of chest radiographs so that they can be used in epidemiological studies...
  13. ncbi request reprint Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies
    Rosanna Lagos
    Centro para la Vacunas en Desarollo Chile, Hospital Roberto del Rio, Santiago, Chile
    Vaccine 21:3730-3. 2003
    ....
  14. doi request reprint Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children
    Rosanna Lagos
    Centro para Vacunas en Desarrollo Chile, Santiago, Chile
    Pediatr Infect Dis J 28:835-7. 2009
    ..Cultivatable RSV in the upper respiratory tract was significantly reduced with motavizumab compared with placebo day 1 post-treatment. No adverse events were considered motavizumab-related by site investigators...